Does Rallies show 13F holders for BLCO?

Yes. Rallies tracks hedge fund and 13F ownership data for BLCO, including fund names, share counts, latest tracked quarter, and position changes when available.

Is BLCO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BLCO. It does not provide personalized investment advice.

BLCO (Bausch + Lomb Corporation) Stock Analysis - Hedge Fund Holdings

Bausch + Lomb Corporation (BLCO) is a publicly traded Healthcare sector company. As of May 20, 2026, BLCO trades at $16.00 with a market cap of $5.74B and a P/E ratio of -26.08. BLCO moved -0.03% today. Year to date, BLCO is -3.57%; over the trailing twelve months it is +37.87%. Its 52-week range spans $10.45 to $21.69. Analyst consensus is neutral with an average price target of $18.60. Rallies surfaces BLCO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BLCO stock?

Hedge funds tracked by Rallies that own BLCO include Icahn Carl, Oaktree Capital, Davidson Kempner, Glenview Capital, and King Street. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Bausch + Lomb Corporation.

BLCO Key Metrics

Key financial metrics for BLCO
Metric	Value
Price	$16.00
Market Cap	$5.74B
P/E Ratio	-26.08
EPS	$-0.62
Dividend Yield	0.00%
52-Week High	$21.69
52-Week Low	$10.45
Volume	310.31K
Avg Volume	0
Revenue (TTM)	$5.21B
Net Income	$-211.00M
Gross Margin	0.00%

Top Hedge Funds Holding BLCO

Icahn Carl holds 3.50M shares of BLCO, changed +0.00% as of Mar 31, 2026.
Oaktree Capital holds 3.38M shares of BLCO, changed +0.00% as of Mar 31, 2026.
Davidson Kempner holds 2.20M shares of BLCO, changed +13.38% as of Mar 31, 2026.
Glenview Capital holds 1.91M shares of BLCO, changed +15.52% as of Mar 31, 2026.
King Street holds 1.14M shares of BLCO, changed -22.39% as of Dec 31, 2024.

Latest BLCO News

Bausch + Lomb jumps after Q1 sales growth and raised 2026 guidance — Apr 30, 2026
Bausch Health Q1 Revenue Up 12% to $2.524B While Net Debt Drops $100M — Apr 30, 2026
Bausch + Lomb Targets Net Zero by 2050 with 10% Power Cut and 50% Lighter Lens Packaging — Apr 22, 2026
Bausch + Lomb falls 3% as investors brace for April 29 earnings — Apr 21, 2026
Bausch + Lomb rises as market prices in 2026 guidance ahead of April earnings — Apr 8, 2026

Recent BLCO Insider Trades

Bailey A Robert D bought 14.60K (~$250.33K) on Mar 6, 2026.
Eldessouky Sam bought 4.00K (~$68.52K) on Mar 6, 2026.
SAUNDERS BRENT L bought 14.70K (~$251.96K) on Mar 6, 2026.

BLCO Analyst Consensus

12 analysts cover BLCO: 0 strong buy, 4 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $18.60.

Common questions about BLCO

Who owns BLCO stock?: Hedge funds tracked by Rallies that own BLCO include Icahn Carl, Oaktree Capital, Davidson Kempner, Glenview Capital, and King Street. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Bausch + Lomb Corporation.
Does Rallies show 13F holders for BLCO?: Yes. Rallies tracks hedge fund and 13F ownership data for BLCO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BLCO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BLCO. It does not provide personalized investment advice.